Ignite Creation Date:
2024-05-06 @ 8:38 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02789332
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2016-05-23
Brief Title:
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel Carboplatin Followed by EpirubicinCyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency
Sponsor:
German Breast Group
Organization:
German Breast Group
Organization Data
Organization:
German Breast Group
Class:
OTHER
Study ID:
GBG90
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German Breast Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |